LOPURIN Drug Patent Profile
✉ Email this page to a colleague
When do Lopurin patents expire, and what generic alternatives are available?
Lopurin is a drug marketed by Abbott and Dr Reddys La and is included in three NDAs.
The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lopurin
A generic version of LOPURIN was approved as allopurinol by WATSON LABS on September 28th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOPURIN?
- What are the global sales for LOPURIN?
- What is Average Wholesale Price for LOPURIN?
Summary for LOPURIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 274 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,943 |
| DailyMed Link: | LOPURIN at DailyMed |
Recent Clinical Trials for LOPURIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
| AbbVie | Phase 2 |
| Masonic Cancer Center, University of Minnesota | N/A |
Pharmacology for LOPURIN
| Drug Class | Xanthine Oxidase Inhibitor |
| Mechanism of Action | Xanthine Oxidase Inhibitors |
US Patents and Regulatory Information for LOPURIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys La | LOPURIN | allopurinol | TABLET;ORAL | 071587-001 | Apr 2, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys La | LOPURIN | allopurinol | TABLET;ORAL | 071586-001 | Apr 2, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOPURIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Abbott | LOPURIN | allopurinol | TABLET;ORAL | 018297-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
